Braveheart Inv Regulatory News (BRH)

12 December 2019

Braveheart Investment Group plc

("Braveheart" or the "Group")

Further investment in Pharm 2 Farm Limited

Braveheart Investment Group plc (AIM: BRH), the fund management and strategic investment group, is pleased to report that it has completed a further investment of £200,000 into Pharm 2 Farm Limited ("P2F"), increasing its holding in P2F from 33.33 per cent. to 51.72 per cent.

This further investment will enable P2F to open a new manufacturing facility in Nottingham and expand its sales team to take advantage of the rapidly developing opportunities in agritech and other innovative applications.

P2F has developed a process to manufacture and coat nanoparticles which have been proven to increase the bioavailability of trace minerals in plant feeds. These trace materials enable plants to grow much more quickly and can be used by growers with their existing fertilisers, for both indoor and field crops. Traditionally, hydroponic plant growing has focused on crops like lettuce, micro-greens, strawberries, tomatoes, etc. In the future, high nutrition crops like chickpeas will need to be grown more quickly with multiple crops each year. The benefits of hydroponics include the ability to grow products closer to consumers, using less energy and producing less pollution, all of which can assist in balancing the needs of the world's population. P2F is also developing applications for the use of its technology in other areas, for example the pharmaceutical and medical sectors.

As at 31 August 2018, P2F had unaudited net liabilities of £17,631 and in the year ended 31 August 2018 incurred an unaudited loss of £20,011.

Trevor Brown, Chief Executive Officer said: "The interest shown in P2F products and technology since we acquired our original investment has significantly exceeded our expectations. As a result, we have decided to step up our investment immediately, thereby providing P2F the funds necessary to accelerate its business plan."

For further information: